PMID: 9451391Feb 6, 1998Paper

Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand

The Medical Journal of Australia
I H YoungChristine F McDonald

Abstract

Evidence shows that patients with chronic obstructive pulmonary disease and a stable daytime PaO2 of 55 mm Hg or less will have longer life expectancy if given supplemental oxygen to keep the PaO2 above 60 mm Hg, preferably for longer than 15 hours a day, including sleep. There is some evidence for improved quality of life. It is reasonable to offer this therapy for other lung diseases which cause chronic hypoxaemia, and there are also less well defined indications for supplemental oxygen during exercise, sleep and air travel.

References

Nov 14, 1992·Lancet·L J RestrickJ A Wedzicha
Dec 1, 1987·Annals of Internal Medicine·K L ChristopherT L Petty

❮ Previous
Next ❯

Citations

Jan 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Joanne CockramSue Jenkins
Feb 3, 2006·International Journal of Clinical Practice·B O'NeillJ Macmahon
Jun 9, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Josephine M CranstonAlan J Crockett
Mar 14, 2003·The Medical Journal of Australia·David K McKenzieUNKNOWN Thoracic Society of Australia and New Zealand
Apr 20, 2007·The Cochrane Database of Systematic Reviews·M L NonoyamaR S Goldstein
Jun 21, 2005·The Medical Journal of Australia·Christine F McDonaldIven H Young
Jan 5, 2002·Internal Medicine Journal·P FrithR Pierce
Jun 20, 2007·The Medical Journal of Australia·Andrew JonesE Haydn Walters
Dec 13, 2005·Treatments in Respiratory Medicine·Thomas J Ringbaek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.